Paul M. Silva, SVP & Controller at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 41,120 shares at $217.68 ($9.0M) on 2020-01-02, disclosed to the SEC on 2020-01-06.
Open-market sale of $9.0M VRTX by SVP & Controller. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $217.68 | 2,842 | $619K | 6.9% |
| 2 | $217.68 | 2,842 | $619K | 6.9% |
| 3 | $218.70 | 10,040 | $2.2M | 24.4% |
| 4 | $219.37 | 12,648 | $2.8M | 30.8% |
| 5 | $219.37 | 12,648 | $2.8M | 30.8% |
| 6 | $220.07 | 100 |
| $22K |
| 0.2% |
| Total | $218.97 avg | 41,120 | $9.0M | 100% |
| Filing → |
| VRTX | SELL | 2021-02-19 | $1.8M | — | Filing → |
| VRTX | SELL | 2021-02-16 | $586K | — | Filing → |
| VRTX | SELL | 2020-08-10 | $564K | — | Filing → |